Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
118 |
Employees |
- |
Revenues (TTM) (Millions $) |
30 |
Net Income (TTM) (Millions $) |
-228 |
Cash Flow (TTM) (Millions $) |
32 |
Capital Exp. (TTM) (Millions $) |
2 |
Momenta Pharmaceuticals Inc
Momenta Pharmaceuticals Inc. is a biotechnology company that specializes in the discovery and development of novel drugs for the treatment of various autoimmune diseases. The company's focus is on developing complex generic drugs, biosimilars, and novel therapeutics. Momenta's innovative technologies aim to enable the company to create more effective and affordable treatments for patients. They have a strong pipeline of potential drugs in various stages of development, and they collaborate with other pharmaceutical companies to bring their products to market. Overall, Momenta Pharmaceuticals Inc. is committed to advancing healthcare by developing cutting-edge treatments for patients in need.
Company Address: 301 Binney Street Cambridge 2142 MA
Company Phone Number: 491-9700 Stock Exchange / Ticker: NASDAQ MNTA
|